BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
Home
»
Newsletters
» BioWorld
BioWorld
March 28, 2016
View Archived Issues
Week in review
Read More
Word on the street
Read More
Week in Washington
Read More
Top 10 biopharmaceutical M&As in 2016
Read More
Human Vaccines Project looks to decode the immune system
Last week, Pfizer Inc. was the latest drug company to sign on to the Human Vaccines Project, a nonprofit public-private partnership with the lofty goal of decoding the immune system to make vaccine development more effective.
Read More
Completed biopharmaceutical mergers and acquisitions: January 1 - March 24, 2016
Read More
Pending biopharmaceutical mergers and acquisitions
Read More
The week's biggest gainers and losers
Read More
BioWorld stock report for public biotechnology companies
Read More
Money raised by biotech in 2016 vs. 2015
Read More
Money raised by biotech: Jan. 1 - March 17, 2016
Read More
